mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion
7680699950010
CH-69995
Injektionsdispersion
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionsdispersion
- Galenic group
- Unknown
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SUS
|
0.1 MGML | Substance | Wirkstoff (Principe actif) |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
0.017 MG | Substance | HBESI |
Authorization holder
Moderna Switzerland GmbH
4052 Basel
Authorization information
- Swissmedic authorization number
- 69995
- Drug name
- mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin, Injektionsdispersion
- Galenic form
- DISII
- ATC Code
- J07BX
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 17/04/2025
- Authorization expiration date
- 16/04/2030
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- mRESVIA Vaccin à ARNm contre le VRS
- Description (DE)
- mRESVIA RSV mRNA Impfstoff
- Market launch
- 15/08/2025
- Narcotic (BTM)
- No
Application methods
IMU
Other package sizes (1)
None
10 FESP
GTIN: None